Glooko, Inc., which developed a platform to manage and chronic disease, announced on 31 January it acquired Berlin-based xbird, which developed JITAI (Just In Time Adaptive Intervention) technologies to further support patients and providers in predicting and managing diabetes.
xBird’s technology can identify health risks for people with diabetes. The technology uses machine learning and artificial intelligence to interpret...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?